Israeli Biotech Firm Trying To Print Organs For Transplants
Image by iStock
Israeli biotech firm CollPlant is trying to patent a technology that that could eventually lead to the three-dimensional printing of hearts, kidneys and other vital human tissues.
CollPlant, based in Ness Ziona, has filed a patent application in the United States for its “bio-ink” – made of a proprietary plant product that mimics the qualities of collagen, a protein responsible for the elasticity of human skin and other organs.
Combined with other hormones and existing human cells, the bio-ink could eventually be used to create organs for those in need – easing pressure on the transplant process, which for the most part relies on harvested organs from the deceased.
“We are promoting commercial collaborations with leading international companies in the field of 3D bio-printing of tissue and organ, with the aim of taking part in providing a solution to the significant need for life saving organs,” Yehiel Tal, CEO of CollPlant, told the Jerusalem Post.
Contact Daniel J. Solomon at [email protected] or on Twitter @DanielJSolomon
A message from our CEO & publisher Rachel Fishman Feddersen
I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.
At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse..
Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.
— Rachel Fishman Feddersen, Publisher and CEO
